The dependency of KRAS mutant tumor cell lines upon CDK6 was readily apparent (rho = −0.38), but was stronger when KRAS, HRAS, NRAS, or BRAF mutant tumor cell line models were combined as a group (rho = −0.43). The gene discussed is KRAS; the disease is neoplasm.